Printer Friendly

CORDIS INTRODUCES PERIPHERAL RADIOLOGY PRODUCTS

 CORDIS INTRODUCES PERIPHERAL RADIOLOGY PRODUCTS
 MIAMI, Aug. 3 /PRNewswire/ -- Cordis Corporation (NASDAQ-NMS: CORD)


today announced the worldwide release of a new line of guiding catheters and guidewires designed for use in diagnosing and treating peripheral vascular disease.
 Enhancing the practice of interventional radiologists and cardiologists, Cordis Peripheral Guiding Catheters and Storq Guidewires aid in the selective placement of balloon angioplasty catheters, devices now used increasingly to open peripheral arteries occluded by the buildup of fatty deposits, or plaque, associated with atherosclerosis. Cordis is also counting on the devices to bolster its standing in interventional radiology, a market the company has long participated in and now is aggressively pursuing.
 Blending a proprietary nylon material with an innovative flex-coil design, Cordis Peripheral Guiding Catheters, which are available in 7 and 8 French sizes, offer the largest inner-lumen diameter of any similar-size devices currently on the market. They also feature a flexible, radioplaque distal tip, which aids their proper placement within the vessel being treated, and a Teflon inner lining, which facilitates the subsequent manipulation of other devices through them. Cordis' newest guiding catheters are viewed as ideal for transporting the increasing number and types of new interventional devices now being used to open blocked peripheral vessels.
 Storq Guidewires which feature a unique unibody design and special inner and outer coils, are highly pushable and steerable. As a result, interventional radiologists and cardiologists can advance the devices across stenotic lesions and total occlusions, the crucial first step in performing a successful angioplasty procedure. The guidewires' silicone coating also facilitates the tracking of the balloon catheter(S) subsequently advanced over the wire.
 Miami-based Cordis Corporation manufactures and markets a variety of medical devices and systems for the angiographic and neuroscience markets. Shares of the company's stock are traded on the NASDAQ National Market under the symbol CORD.
 -0- 8/3/92
 /CONTACT: Chick McDowell, vice president, corporate relations and assistant secretary of Cordis Corporation, 305-824-2821/
 (CORD) CO: Cordis Corporation ST: Florida IN: MTC SU: PDT


JB-SS -- FL003 -- 6002 08/03/92 09:07 EDT
COPYRIGHT 1992 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1992 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Aug 3, 1992
Words:340
Previous Article:CORDIS INTRODUCES PERIPHERAL RADIOLOGY PRODUCTS
Next Article:CONTROL DATA SYSTEMS STOCK BEGINS TRADING ON NASDAQ; COMPANY ANNOUNCES NEW BOARD OF DIRECTORS


Related Articles
CORDIS INTRODUCES PERIPHERAL RADIOLOGY PRODUCTS
CORDIS INTRODUCES PERIPHERAL RADIOLOGY PRODUCTS
CORDIS GAINS RIGHTS TO ADDITIONAL STENT PATENTS
Cordis Endovascular, a Division of Cordis Corporation, Supports Peripheral Artery Disease Guidelines Released By the American Heart Association and...
New Data Demonstrate Continued Safety and Efficacy of Cordis Endovascular OPTEASE(R) Vena Cava Filter.
Physicians Now Have a New Treatment Option for Patients With a Common Vascular Disease Affecting the Legs.
Cordis Announces Nationwide Introduction of Breakthrough Devices to Treat Artery Blockages in Leg.
Cordis Announces Europe, Middle East and Africa (EMEA) Launch of Breakthrough Devices to Treat Artery Blockages in Leg.
Cordis Corporation and ClearStream Technologies Group, plc, Sign Distribution Agreement for Peripheral Angioplasty Balloon Catheters.
Cordis Corporation and ClearStream Technologies Group, plc, Sign Distribution Agreement for Peripheral Angioplasty Balloon Catheters.

Terms of use | Copyright © 2016 Farlex, Inc. | Feedback | For webmasters